Literature DB >> 28884608

Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use.

Petr Dulicek1, Eva Ivanova1, Milan Kostal1, Petr Sadilek1, Martin Beranek2, Pavel Zak1, Jana Hirmerova3,4.   

Abstract

Thrombotic diathesis has been a well-known complication of oral contraceptive use for more than 50 years. This is true not only for venous thrombosis but also for an arterial one. The etiology is usually multifactorial and depends on several additional risk factors. We analyzed the prevalence of inherited and acquired thrombophilia in a cohort of 770 females who had a thrombotic event in association with oral contraceptive use (700 women with venous thromboembolism [VTE], 70 with stroke). Moreover, we tried to identify additional risk factors. Inherited thrombophilia was found in 44.5% with higher frequency in the cohort with VTE (42%) than in females with stroke (24%). The most frequent finding was factor V Leiden. Cigarette smoking was significantly more frequent in the group with stroke (50% vs 25%). The prevalence of cigarette smoking in the group with VTE did not exceed the frequency in general population. Women on oral contraceptive pills have higher risk of venous as well as arterial thrombosis. The risk of venous thrombosis is increased in females with inherited thrombophilia, whereas those with some additional acquired risk factors (especially smoking) may be predisposed to arterial thrombosis. However, the absolute risk of thrombosis in healthy women is low, far less than the risk of unintended pregnancy. Moreover, the risk may be reduced by keeping some rules before the prescription of the pills, healthy life style, and a proper choice of contraception.

Entities:  

Keywords:  hormonal contraceptive pills; smoking; stroke; thrombophilia; venous thromboembolism

Mesh:

Substances:

Year:  2017        PMID: 28884608      PMCID: PMC6714869          DOI: 10.1177/1076029617727857

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  27 in total

1.  Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.

Authors:  J M Kemmeren; A Algra; D E Grobbee
Journal:  BMJ       Date:  2001-07-21

2.  Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects.

Authors:  K W Bloemenkamp; F R Rosendaal; F M Helmerhorst; J P Vandenbroucke
Journal:  Arch Intern Med       Date:  2000-01-10

3.  Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke.

Authors:  Ida Martinelli; Tullia Battaglioli; Ilaria Burgo; Sandro Di Domenico; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2006-06       Impact factor: 9.941

Review 4.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

Review 5.  Clinical practice. Hormonal contraception in women of older reproductive age.

Authors:  Andrew M Kaunitz
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

6.  Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.

Authors:  Morteza Abdollahi; Mary Cushman; Frits R Rosendaal
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

7.  Venous thromboembolism among new users of different oral contraceptives.

Authors:  R M Herings; J Urquhart; H G Leufkens
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

8.  Contraceptives and cerebral thrombosis: a five-year national case-control study.

Authors:  Øjvind Lidegaard; Svend Kreiner
Journal:  Contraception       Date:  2002-03       Impact factor: 3.375

9.  A prospective study of the incidence of deep-vein thrombosis within a defined urban population.

Authors:  M Nordström; B Lindblad; D Bergqvist; T Kjellström
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

Review 10.  Hormone therapy and thromboembolic disease.

Authors:  Tullia Battaglioli; Ida Martinelli
Journal:  Curr Opin Hematol       Date:  2007-09       Impact factor: 3.284

View more
  3 in total

1.  Cryptogenic acute limb ischemia: a retrospective cohort study defining a previously undescribed clinical entity.

Authors:  Dylan Mart; Joseph Shatzel; Thomas DeLoughery
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

2.  Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report.

Authors:  Norberto B Fiorini; Fernando Garagoli; Rosana C Bustamante; Rodolfo Pizarro
Journal:  Eur Heart J Case Rep       Date:  2021-01-21

3.  Examination of in Factor V Leiden and Prothrombin II Thrombophilic Mutations in Czech Young Women Using ddPCR-Prevalence and Cost-Benefit Analysis.

Authors:  Petra Riedlova; Dagmar Kramna; Silvie Ostrizkova; Hana Tomaskova; Vitezslav Jirik
Journal:  Healthcare (Basel)       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.